 GENEVA, Switzerland January 3 , 202 2 ObsEva SA NASDAQ: OBSV; SIX: OBSN, a biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health, today announced that Company Management will provide a corporate update at the upcoming H.C. Wainwright BioConnect Conference, to be held January 10-13, 2022. 